{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:01:11Z","timestamp":1784293271155,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001637","name":"Trinity College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["CSC202008890045"],"award-info":[{"award-number":["CSC202008890045"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.yexcr.2024.113995","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:50:59Z","timestamp":1710316259000},"page":"113995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Targeting inhibitor of apoptosis proteins (IAPs) enhances susceptibility of oral squamous carcinoma cells to cisplatin"],"prefix":"10.1016","volume":"437","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3220-5566","authenticated-orcid":false,"given":"Tianyi","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Magnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Rynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"O'Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Hannon","family":"Barroeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela M.","family":"Zisterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.yexcr.2024.113995_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2024.113995_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.761379","article-title":"The molecular basis and therapeutic aspects of cisplatin resistance in oral squamous cell carcinoma","volume":"11","author":"Cheng","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.113995_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2012.07.003","article-title":"Subcellular targets of cisplatin cytotoxicity: an integrated view","volume":"136","author":"Sancho-Mart\u00ednez","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.yexcr.2024.113995_bib4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/jjco\/hyz112","article-title":"Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE)","volume":"49","author":"Terada","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2024.113995_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fonc.2014.00197","article-title":"X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy","volume":"4","author":"Obexer","year":"2014","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.yexcr.2024.113995_bib6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10495-017-1375-1","article-title":"Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)","volume":"22","author":"Rathore","year":"2017","journal-title":"Apoptosis"},{"issue":"8","key":"10.1016\/j.yexcr.2024.113995_bib7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/jso.21408","article-title":"Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis","volume":"100","author":"Xiang","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.yexcr.2024.113995_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1746-1596-6-49","article-title":"X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma","volume":"6","author":"Zhang","year":"2011","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.yexcr.2024.113995_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2015.04.009","article-title":"Survivin over-expression is correlated with a poor prognosis in esophageal cancer patients","volume":"446","author":"Xia","year":"2015","journal-title":"Clin. Chim. Acta; Int. J. Clin. Chem."},{"issue":"1","key":"10.1016\/j.yexcr.2024.113995_bib10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3892\/mmr.2015.3372","article-title":"Inhibition of livin expression suppresses cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma cells","volume":"12","author":"Zhuang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.yexcr.2024.113995_bib41","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/jvi.68.4.2521-2528.1994","article-title":"An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys\/His sequence motifs","volume":"68","author":"Birnbaum","year":"1994","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.yexcr.2024.113995_bib11","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1074\/jbc.M207197200","article-title":"Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac\/DIABLO","volume":"278","author":"Hu","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.yexcr.2024.113995_bib12","first-page":"993","article-title":"Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells","volume":"14","author":"Nomura","year":"2005","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.yexcr.2024.113995_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0033-1333637","article-title":"Increased expression of survivin in hepatoblastoma after chemotherapy","volume":"23","author":"Uehara","year":"2013","journal-title":"Eur. J. Pediatr. Surg."},{"issue":"9","key":"10.1016\/j.yexcr.2024.113995_bib14","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1074\/jbc.M113.526152","article-title":"Receptor-interacting protein 1 increases chemoresistance by maintaining inhibitor of apoptosis protein levels and reducing reactive oxygen species through a microRNA-146a-mediated catalase pathway","volume":"289","author":"Wang","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.yexcr.2024.113995_bib15","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1021\/jm030420+","article-title":"Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database","volume":"47","author":"Nikolovska-Coleska","year":"2004","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.yexcr.2024.113995_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23030621","article-title":"The application of embelin for cancer prevention and therapy","volume":"23","author":"Ko","year":"2018","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.yexcr.2024.113995_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd3627","article-title":"Targeting IAP proteins for therapeutic intervention in cancer","volume":"11","author":"Fulda","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.yexcr.2024.113995_bib18","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/1535-7163.MCT-06-0810","article-title":"Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells","volume":"6","author":"Weisberg","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.yexcr.2024.113995_bib19","first-page":"191","article-title":"The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway","volume":"55","author":"Coyle","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.113995_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35860-z","article-title":"DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death","volume":"8","author":"Thibault","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.yexcr.2024.113995_bib21","first-page":"943","article-title":"Debio 1143, an antagonist of multiple inhibitor-of-apoptosis proteins, activates apoptosis and enhances radiosensitization of non-small cell lung cancer cells in vitro","volume":"4","author":"Liu","year":"2014","journal-title":"Am. J. Cancer Res."},{"issue":"11","key":"10.1016\/j.yexcr.2024.113995_bib22","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijom.2008.06.004","article-title":"Expression of cIAP-1 correlates with nodal metastasis in squamous cell carcinoma of the tongue","volume":"37","author":"Qi","year":"2008","journal-title":"Int. J. Oral Maxillofac. Surg."},{"issue":"9","key":"10.1016\/j.yexcr.2024.113995_bib23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/bjc.2011.387","article-title":"Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma","volume":"105","author":"Nagata","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.yexcr.2024.113995_bib24","first-page":"1657","article-title":"Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas","volume":"41","author":"Rheinwald","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2024.113995_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115646","article-title":"Cisplatin induces autophagy-associated apoptosis in human oral squamous cell carcinoma (OSCC) mediated in part through reactive oxygen species","volume":"427","author":"Magnano","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"22","key":"10.1016\/j.yexcr.2024.113995_bib26","doi-asserted-by":"crossref","first-page":"9384","DOI":"10.1158\/0008-5472.CAN-08-2655","article-title":"SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1\/2 and XIAP","volume":"68","author":"Lu","year":"2008","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.yexcr.2024.113995_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4161\/cbt.20563","article-title":"AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer","volume":"13","author":"Brunckhorst","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2024.113995_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5815493","article-title":"Low survival rates of oral and oropharyngeal squamous cell carcinoma","volume":"2017","author":"Le Campion","year":"2017","journal-title":"Int. J. Dentistry"},{"issue":"15","key":"10.1016\/j.yexcr.2024.113995_bib45","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2024.113995_bib29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1758-3284-1-6","article-title":"Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma","volume":"1","author":"Matta","year":"2009","journal-title":"Head Neck Oncol."},{"issue":"4","key":"10.1016\/j.yexcr.2024.113995_bib42","first-page":"80","article-title":"Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation?","volume":"4","author":"Chapman","year":"2016","journal-title":"Ann. Transl. Med."},{"issue":"7","key":"10.1016\/j.yexcr.2024.113995_bib30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1634\/theoncologist.2016-0496","article-title":"FDA approval summary: pembrolizumab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma with disease progression on or after platinum-containing chemotherapy","volume":"22","author":"Larkins","year":"2017","journal-title":"Oncologist"},{"issue":"18","key":"10.1016\/j.yexcr.2024.113995_bib31","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1158\/1078-0432.CCR-16-0308","article-title":"A phase I dose-escalation study evaluating the safety tolerability and pharmacokinetics of CUDC-427, a potent, oral, monovalent IAP antagonist, in patients with refractory solid tumors","volume":"22","author":"Tolcher","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2024.113995_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102492","article-title":"Inhibiting the inhibitors: development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck","volume":"113","author":"Ferris","year":"2023","journal-title":"Cancer Treat Rev."},{"issue":"9","key":"10.1016\/j.yexcr.2024.113995_bib33","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00784-016-1741-3","article-title":"Cytotoxic effects of SMAC-mimetic compound LCL161 in head and neck cancer cell lines","volume":"20","author":"Brands","year":"2016","journal-title":"Clin. Oral Invest."},{"issue":"10","key":"10.1016\/j.yexcr.2024.113995_bib34","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jcms.2019.07.022","article-title":"Targeting inhibitors of apoptosis in oral squamous cell carcinoma in vitro","volume":"47","author":"Scheurer","year":"2019","journal-title":"J. Cranio-Maxillo-Fac. Surg."},{"issue":"7","key":"10.1016\/j.yexcr.2024.113995_bib35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jcms.2020.05.007","article-title":"Sensitization of head and neck squamous cell carcinoma to apoptosis by combinational SMAC mimetic and Fas ligand-Fc treatment in vitro","volume":"48","author":"Brands","year":"2020","journal-title":"J. Cranio-Maxillo-Fac. Surg."},{"key":"10.1016\/j.yexcr.2024.113995_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2022.100579","article-title":"Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin","volume":"32","author":"Coyle","year":"2022","journal-title":"Cancer Treatment Res. Commun."},{"issue":"18","key":"10.1016\/j.yexcr.2024.113995_bib44","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/1535370216661779","article-title":"The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-\u03b1 and TRAIL-induced apoptosis","volume":"241","author":"El-Mesery","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"1\u20133","key":"10.1016\/j.yexcr.2024.113995_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2009.11.003","article-title":"XIAP-mediated protection of H460 lung cancer cells against cisplatin","volume":"627","author":"Cheng","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.113995_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1254\/jphs.12137FP","article-title":"Embelin induces apoptosis in human glioma cells through inactivating NF-\u03baB","volume":"121","author":"Park","year":"2013","journal-title":"J. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2024.113995_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2011.04.015","article-title":"Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN","volume":"308","author":"Heo","year":"2011","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.yexcr.2024.113995_bib39","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.molcel.2011.06.006","article-title":"The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs","volume":"43","author":"Tenev","year":"2011","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.yexcr.2024.113995_bib40","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.18632\/oncotarget.2746","article-title":"Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis","volume":"6","author":"Shi","year":"2015","journal-title":"Oncotarget"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T23:04:55Z","timestamp":1712185495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482724000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0014482724000867"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.113995","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting inhibitor of apoptosis proteins (IAPs) enhances susceptibility of oral squamous carcinoma cells to cisplatin","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.113995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113995"}}